AANPCBxfFNPxfPracticexfV3
1. ~x f Ax f nursex f practitionerx f suspectsx f bacterialx f pneumoniax f inx f anx f olderx f ad
ultx f pa-
tient.xfWhichxfofxfthexffollowingxffindingsxfwouldxfbexfanxfindicationxfforxfhospita
lxfadmission?
Selectxfonlyxfonexfoption.xf
A
Confusedxfmentalxfstatu
sxfB
Respiratoryxfratexfofxf24xf
C
Cracklesxfinxfthexflungxfbasesxf
D
Whitex f bloodx f countx f 9.5:x f A
2. ~x f Ax f middlex f adultx f malex f presentsx f forx f re-
evaluationx f ofx f hisx f asthmax f control.x f Lastxfmonth,x f hisx f asthmax f regimenx f wasx f incr
easedx f tox f ax f lowx f dosex f inhaledx f corticosteroidxfandxfshortxfactingxfbetaxfagonistxfas
xfneeded. xfHe xfstatesxfthatxfhexfuses xfhis xfrescuexfinhalerx f onex f timex f ax f weekx f andx f h
asx f awokenx f withx f asthmax f symptomsx f oncex f inx f thexflastx f month.x f Hisx f peakx f flowx
f isx f inx f thex f greenx f zone.x f Thex f mostx f appropriatex f planx f forxfthisxfpatientxfisxfto:
Selectxfonlyxfonexfoption.xf
A
continuexfonxfcurrentxftherapy.xf
B
addxfaxflongxfactingxfbetaxfagonist.
xfC
discontinuexfthexfinhaledxfcorticosteroid.xf
D
encouragex f increasedx f usex f ofx f thex f rescuex f inhaler.:x f A
3. ~xfAxfmenopausalxffemalexfhasxfreceivedxfaxfnewxfdiagnosisxfofxfbreastxfcancer.xfWhich
xfofxfthexffollowing xfriskxffactorsxfwouldxfbexfofxfgreatest xfconcern?
Selectxfonlyxfonexfoption.xf
A
, AANPCBxfFNPxfPracticexfV3
Currentx f usex f ofx f hormonex f therapy
, AANPCBxfFNPxfPracticexfV3
B
Usexfofxftobaccoxfproductsxf
C
First-
degreexfrelativexfwithxfbreastxfcancerxfD
Earlyx f onsetx f ofx f menopause:x f C
4. ~x f AxfmiddlexfadultxfmalexfwithxfaxfBMIxfofxf19xfandxfaxfdiagnosisxfofxfGERDxfpresentsxffo
rx f axffollow-upxfvisitxfafterxfusingxfover-the-
counterxffamotidinexf(Pepcid)xfforxf6xfweeks.xfWhichxfofxfthexffollowingxfisxfthexfbestxft
reatmentxfoptionxfforxfthisxfpatient?
Selectxfonlyxfonexfoption
.xfA
Prescribexfaxfprotonxfpumpxfinhibitor
xfB
Weightxfreductionxf
C
PrescribexfH2xfreceptorxfantagonis
txfD
Endoscopicx f evaluation:x f A
5. ~xfWhichxfofxfthexffollowingxfisxfthexfmostxfcommonxfriskxffactorxfforxfdeveloping
xfsevere xfhyperbilirubinemia xfinxfthe xfnewborn?
Selectxfonlyxfonexfoption.xf
A
Exclusivexfformulaxffeedingxf
B
Cesareanxfsectionxfbirth
xfC
Bloodxfincompatibilityxfwithxfthexfmotherxf
D
Gestationalx f diabetes:x f C
6. ~xfThexfmostxfcommonxfskinxfcancerxfis
:xfSelectxfonlyxfonexfoption.
, AANPCBxfFNPxfPracticexfV3
A
1. ~x f Ax f nursex f practitionerx f suspectsx f bacterialx f pneumoniax f inx f anx f olderx f ad
ultx f pa-
tient.xfWhichxfofxfthexffollowingxffindingsxfwouldxfbexfanxfindicationxfforxfhospita
lxfadmission?
Selectxfonlyxfonexfoption.xf
A
Confusedxfmentalxfstatu
sxfB
Respiratoryxfratexfofxf24xf
C
Cracklesxfinxfthexflungxfbasesxf
D
Whitex f bloodx f countx f 9.5:x f A
2. ~x f Ax f middlex f adultx f malex f presentsx f forx f re-
evaluationx f ofx f hisx f asthmax f control.x f Lastxfmonth,x f hisx f asthmax f regimenx f wasx f incr
easedx f tox f ax f lowx f dosex f inhaledx f corticosteroidxfandxfshortxfactingxfbetaxfagonistxfas
xfneeded. xfHe xfstatesxfthatxfhexfuses xfhis xfrescuexfinhalerx f onex f timex f ax f weekx f andx f h
asx f awokenx f withx f asthmax f symptomsx f oncex f inx f thexflastx f month.x f Hisx f peakx f flowx
f isx f inx f thex f greenx f zone.x f Thex f mostx f appropriatex f planx f forxfthisxfpatientxfisxfto:
Selectxfonlyxfonexfoption.xf
A
continuexfonxfcurrentxftherapy.xf
B
addxfaxflongxfactingxfbetaxfagonist.
xfC
discontinuexfthexfinhaledxfcorticosteroid.xf
D
encouragex f increasedx f usex f ofx f thex f rescuex f inhaler.:x f A
3. ~xfAxfmenopausalxffemalexfhasxfreceivedxfaxfnewxfdiagnosisxfofxfbreastxfcancer.xfWhich
xfofxfthexffollowing xfriskxffactorsxfwouldxfbexfofxfgreatest xfconcern?
Selectxfonlyxfonexfoption.xf
A
, AANPCBxfFNPxfPracticexfV3
Currentx f usex f ofx f hormonex f therapy
, AANPCBxfFNPxfPracticexfV3
B
Usexfofxftobaccoxfproductsxf
C
First-
degreexfrelativexfwithxfbreastxfcancerxfD
Earlyx f onsetx f ofx f menopause:x f C
4. ~x f AxfmiddlexfadultxfmalexfwithxfaxfBMIxfofxf19xfandxfaxfdiagnosisxfofxfGERDxfpresentsxffo
rx f axffollow-upxfvisitxfafterxfusingxfover-the-
counterxffamotidinexf(Pepcid)xfforxf6xfweeks.xfWhichxfofxfthexffollowingxfisxfthexfbestxft
reatmentxfoptionxfforxfthisxfpatient?
Selectxfonlyxfonexfoption
.xfA
Prescribexfaxfprotonxfpumpxfinhibitor
xfB
Weightxfreductionxf
C
PrescribexfH2xfreceptorxfantagonis
txfD
Endoscopicx f evaluation:x f A
5. ~xfWhichxfofxfthexffollowingxfisxfthexfmostxfcommonxfriskxffactorxfforxfdeveloping
xfsevere xfhyperbilirubinemia xfinxfthe xfnewborn?
Selectxfonlyxfonexfoption.xf
A
Exclusivexfformulaxffeedingxf
B
Cesareanxfsectionxfbirth
xfC
Bloodxfincompatibilityxfwithxfthexfmotherxf
D
Gestationalx f diabetes:x f C
6. ~xfThexfmostxfcommonxfskinxfcancerxfis
:xfSelectxfonlyxfonexfoption.
, AANPCBxfFNPxfPracticexfV3
A
